WEDNESDAY, Aug. 27, 2025 (HealthDay News) — Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial.  The company plans to seek global regulatory approval later this year. The study included people with overweight, obesity and type 2Continue Reading

FRIDAY, Aug. 15, 2025 (HealthDay News) — Nearly half of U.S. adults should receive earlier treatment for high blood pressure, including lifestyle changes and medications, according to a set of new guidelines issued by America’s top heart health groups. The guidelines call for early and more individualized treatment for theContinue Reading